跳至主要内容
临床试验/CTRI/2023/11/060100
CTRI/2023/11/060100招募中不适用

Optimal strategy for Cardiovascular risk assessment in Spondyloarthritis : A comparative analysis between traditional cardiovascular risk score (QRISK3 score) versus traditional risk score supplemented with either Carotid ultrasound or Coronary CT angiography

All India Institute of Medical Sciences (AIIMS), Raipur1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2023年12月1日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
66
试验地点
1
主要终点
To compare the accuracy of Cardiovascular (CV) risk estimation in SpA patients by traditional CV risk prediction tool (QRISK3) alone versus traditional CV risk score (QRISK3) combined with either carotid US or coronary CT angiography

研究概览

简要总结

Inflammatory rheumatic diseases are traditionally considered a risk factor for cardiovascular diseases. However, EULAR has advocated the multiplication of cardiovascular risk-score estimated by traditional cardiovascular risk-scoring tools in patients of rheumatoid arthritis patients by a certain factor. There is no such advice for patients with spondyloarthritis. Besides, all the previous studies failed to identify any higher cardiovascular risk in patients with spondyloarthritis. There is a possibility that the traditional cardiovascular risk score may underestimate the actual cardiovascular risk in patients with spondyloarthritis. This current study is planned to see whether the traditional cardiovascular risk score used for the general population truly underestimates the cardiovascular risk in patients of spondyloarthritis and whether other strategies like carotid ultrasound and CT angiography fare better for cardiovascular risk assessment amongst the patients of spondyloarthritis.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Newly diagnosed case/previously diagnosed case of axial Spondyloarthritis, Ankylosing Spondylitis, or Psoriatic Arthritis.

排除标准

  • Pregnant women and lactating mother
  • History any cardiovascular or cerebrovascular events
  • History of any allergy to contrast agents
  • Presence of chronic kidney disease which is a contraindication for contrast use during CT scan
  • Any other contraindications for radiological investigations like CT or Ultrasound.

结局指标

主要结局

To compare the accuracy of Cardiovascular (CV) risk estimation in SpA patients by traditional CV risk prediction tool (QRISK3) alone versus traditional CV risk score (QRISK3) combined with either carotid US or coronary CT angiography

时间窗: End of study period

次要结局

  • To compare the cardiovascular (CV) risk estimation by QRISK3 combined with carotid US versus QRISK3 combined with coronary CT angiography in SpA patients for finding out the best tool for CV risk screening.(End of study period)

研究者

发起方
All India Institute of Medical Sciences (AIIMS), Raipur
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Joydeep Samanta

All India Institute of Medical Sciences (AIIMS), Raipur

研究点 (1)

Loading locations...

相似试验